VVOS dividend history
Vivos Therapeutics Inc. (VVOS) dividend declarations and ex-dividend dates - real-time wire coverage of every payout disclosure.
Which date decides who gets paid? Dividend dates explained
Recent dividend items
- Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine CentersLITTLETON, Colo., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or "the Company") (NASDAQ:VVOS), a leading medical device and healthcare services company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from obstructive sleep apnea ("OSA") and other sleep disorders, today announced that new OSA patient referrals flowing into its Nevada Sleep & Airway Medicine Centers have increased 212% over the most recent six-week period versus the prior six-week period. Since June 1, the total average weekly number of referrals has risen nearly five-fold and has continued to grow week over week. The Company recently an
- Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights OfferingLITTLETON, Colo., June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including mild-to-severe obstructive sleep apnea ("OSA"), today announced that it intends to file a registration statement with the U.S. Securities and Exchange Commission (the "SEC") for a proposed rights offering pursuant to which the Company would distribute, as a dividend, transferable subscription rights to its shareholders. The Company currently expects to file a registration statement in connection with th
- Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote "FOR" Re-Election of Its Highly Qualified DirectorsGEORGE TOWN, Cayman Islands, May 20, 2024 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, today issued the following statement commenting on the reports issued by Institutional Shareholder Services ("ISS") and Glass Lewis regarding the Company's May 28, 2024 Annual General Meeting of Shareholders: The Company strongly disagrees with the recommendations to withhold votes from Linda Beidler-D'Aguilar, Brian E. Butler and Leonard J. Sokolow for re-election to the Company's Board of Directors (the "Board"). For the reasons provided below, as well as those provided in th